Acoramidis developer BridgeBio nabs up to $1.25bn in funding

The financing was provided by Blue Owl Capital and Canada Pension Plan Investment Board, through its subsidiary CPPIB Credit Investments.

23 January 2024•2 mins read
LinkedInXEmail
LinkedInXEmail

Related articles